BioSpace News Archive

Amphera B.V., an advanced-clinical-stage biotechnology company developing dendritic cell therapies to treat cancer, presented data from patients that received a combination of its dendritic cell therapy product MesoPher with marketed checkpoint inhibitors, to treat mesothelioma. The data was presented at the AACR Annual Meeting 2019 in Atlanta, Georgia.

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company developing novel antibacterials to treat serious drug-resistant infections, today announced the initiation of the ATTACK (AcinetobacterTreatment Trial Against Colistin) Phase 3 pivotal clinical trial to evaluate ETX2514SUL, a fixed-dose combination of its broad-spectrum β-lactamase inhibitor ETX2514 with sulbactam,

The National Basketball Athletic Trainers’ Association welcomes KT Tape, the leading producer of kinesiology tape and related sports performance products in the retail market, to the NBATA partnership family as the “Official Kinesiology Tape Sponsor of NBATA”.

Acceleron Pharma Inc., a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to treat serious and rare diseases, announced it is discontinuing development of ACE-2494, a systemic muscle agent the company had been studying in a Phase 1 healthy volunteer trial for the potential treatment of neuromuscular disorders.

BD announced that it will conduct a live webcast of its second fiscal quarter 2019 earnings conference call on Thursday, May 9, 2019, at 8:00 a.m..

Neuraxpharm Group, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces expansion in Eastern Europe with the launch of Neuraxpharm Polska and the appointment of Dr. Wojciech Góra as General Manager to spearhead the business.

NEJM Knowledge+ was recently awarded an educational grant from the Opioid Analgesic Risk Evaluation and Mitigation Strategies Program Companies to extend the delivery of high-quality continuing medical education to health care providers.

Program Fosters Use of Original Written and Visual Art to Share Experiences with Amyotrophic Lateral Sclerosis (ALS)

Silicon Valley Bank, the bank of the world’s most innovative companies and their investors, today announced that it led a $55 million senior secured term loan to US HealthVest, a developer and operator of behavioral health facilities.

Winners Competing For Up To $93,000 in Prizes, Including a $20,000 School Science Lab Makeover Support Package